These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9424845)
41. Comparison of the directigen flu A+B membrane enzyme immunoassay with viral culture for rapid detection of influenza A and B viruses in respiratory specimens. Cazacu AC; Chung SE; Greer J; Demmler GJ J Clin Microbiol; 2004 Aug; 42(8):3707-10. PubMed ID: 15297520 [TBL] [Abstract][Full Text] [Related]
42. Development of latex turbidimetric immunoassay for rapid and sensitive detection of influenza virus. Nemoto H; Komoriya T; Kohno H Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2007; 18(2):117-26. PubMed ID: 18154440 [TBL] [Abstract][Full Text] [Related]
43. High prevalence of influenza specific antibody secreting cells in nasal mucosa. Brokstad KA; Cox RJ; Eriksson JC; Olofsson J; Jonsson R; Davidsson A Scand J Immunol; 2001; 54(1-2):243-7. PubMed ID: 11439173 [TBL] [Abstract][Full Text] [Related]
44. Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. Rahman M; Vandermause MF; Kieke BA; Belongia EA Diagn Microbiol Infect Dis; 2008 Oct; 62(2):162-6. PubMed ID: 18060723 [TBL] [Abstract][Full Text] [Related]
45. [Importance of secretory IgA in human body fluids. I. Development of an enzyme immunoassay for secretory IgA]. Seyfarth M; Brock J; Fiebig H; Edelmann J; Seidel B Allerg Immunol (Leipz); 1987; 33(3):147-52. PubMed ID: 2961224 [TBL] [Abstract][Full Text] [Related]
46. [Indication of the influenza virus in clinical samples using immunoenzyme and lanthanide immunofluorescence analyses]. Khristova ML; Busse TL; Zagidullin NV; Leonov SV; Rybalko SL; Frolov AF; Kharitonenkov IG Vopr Virusol; 1989; 34(5):538-42. PubMed ID: 2692302 [TBL] [Abstract][Full Text] [Related]
47. [The antigens and nucleotide sequences of influenza A and B viruses in the lymphocytes of human peripheral blood]. Isaeva EI; Dobretsova AG; Nolandt OV; Pliusnin AZ; Rovnova ZI; Viazov SO Vopr Virusol; 1992; 37(1):40-3. PubMed ID: 1413712 [TBL] [Abstract][Full Text] [Related]
48. [Immunoenzyme test system based on F(ab)2-antibody fragments for demonstrating influenza virus hemagglutinin]. Leonov SV; Zakomyrdin IuA; Eggert GI; Sokolova MV; Khristova ML Vopr Virusol; 1987; 32(4):498-502. PubMed ID: 3318135 [No Abstract] [Full Text] [Related]
49. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
50. Natural immunity to influenza A and B among Saudi blood donors in Al Madinah Al Munawarah, Saudi Arabia. Mahallawi WH; Ibrahim NA; Alahmadi KS; Al-Harbi AK; Almughthawi MA; Alhazmi OA; Alsehli FH; Khabour OF Saudi Med J; 2020 Dec; 41(12):1301-1307. PubMed ID: 33294887 [TBL] [Abstract][Full Text] [Related]
51. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Lindemann M; Witzke O; Lütkes P; Fiedler M; Kreuzfelder E; Philipp T; Roggendorf M; Grosse-Wilde H Clin Immunol; 2006 Sep; 120(3):342-8. PubMed ID: 16631409 [TBL] [Abstract][Full Text] [Related]
52. [The dynamics of anti-influenza immunity in sailors of the Baltic Fleet]. Protasov VV; Slezinger VM; Antiukhova MP Voen Med Zh; 1996 Sep; 317(9):33-4. PubMed ID: 8992744 [No Abstract] [Full Text] [Related]
53. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza. Mancini N; Solforosi L; Clementi N; De Marco D; Clementi M; Burioni R Antiviral Res; 2011 Oct; 92(1):15-26. PubMed ID: 21798290 [TBL] [Abstract][Full Text] [Related]
54. [The phenotypic characteristics of healthy carriers of the antigenic structures of the influenza A virus]. Tsybalova LM; Sominina AA; Popova TL; Filippova IE; Zibina EA; Bekhtereva TA; Konovalova II; Voĭtsekhovskaia EM; Semilutskaia IB Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):32-6. PubMed ID: 8701652 [TBL] [Abstract][Full Text] [Related]
55. [Use of detergents for elimination of non-specific reactions of monoclonal antibodies]. Ivanova IA; Monaenkov AO; Peshkova VG; Medvedeva NA Klin Lab Diagn; 2004 Jan; (1):36-9. PubMed ID: 15022611 [TBL] [Abstract][Full Text] [Related]
56. Influenza virus infection and risk of acute myocardial infarction. Guan XR; Li X; Xin XM; Jiang LX; Cui LY; Wang LF; Li HY Inflammation; 2008 Aug; 31(4):266-72. PubMed ID: 18568394 [TBL] [Abstract][Full Text] [Related]
57. [Duration of detection of influenza virus markers in human blood lymphocytes]. Isaeva EI; Rovnova ZI; Alipova TA; Viazov SO; Krylov VF; Pliusnin AZ Vopr Virusol; 1994; 39(6):262-6. PubMed ID: 7716919 [No Abstract] [Full Text] [Related]
58. [Two cases of central nervous system manifestation caused by co-infection with influenza type A/H3 and type B]. Tanaka T; Oba K; Oda T; Takayama I; Nakauchi M; Kageyama T Kansenshogaku Zasshi; 2013 Sep; 87(5):618-9. PubMed ID: 24195173 [No Abstract] [Full Text] [Related]